Package 62135-312-12

Brand: anagrelide

Generic: anagrelide
NDC Package

Package Facts

Identity

Package NDC 62135-312-12
Digits Only 6213531212
Product NDC 62135-312
Product ID 62135-312_13156e50-28d1-0994-e063-6394a90a16ec
Description

120 CAPSULE in 1 BOTTLE (62135-312-12)

Marketing

Marketing Status
Marketed Since 2024-02-05
Brand anagrelide
Generic anagrelide
Sample Package No

Linked Drug Pages (1)

Anagrelide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "13156e50-28d1-0994-e063-6394a90a16ec", "openfda": {"upc": ["0362135312121", "0362135313609"], "unii": ["VNS4435G39"], "rxcui": ["597850", "597852"], "spl_set_id": ["e031dfb3-56e1-4fea-95f2-c2936e2057a0"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (62135-312-12)", "package_ndc": "62135-312-12", "marketing_start_date": "20240205"}], "brand_name": "Anagrelide", "product_id": "62135-312_13156e50-28d1-0994-e063-6394a90a16ec", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Platelet Production [PE]", "Phosphodiesterase 3 Inhibitors [MoA]", "Platelet-reducing Agent [EPC]"], "product_ndc": "62135-312", "generic_name": "Anagrelide", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Anagrelide", "active_ingredients": [{"name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS", "strength": ".5 mg/1"}], "application_number": "ANDA076683", "marketing_category": "ANDA", "marketing_start_date": "20050418", "listing_expiration_date": "20261231"}